Genetic Etiology and Evaluation of Sudden Cardiac Death

被引:6
|
作者
Dolmatova, Elena [1 ]
Mahida, Saagar [2 ]
Ellinor, Patrick T. [1 ,3 ]
Lubitz, Steven A. [1 ,3 ]
机构
[1] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA USA
[2] Leeds Gen Infirm, Leeds LS1 3EX, W Yorkshire, England
[3] Massachusetts Gen Hosp, Cardiac Arrhythmia Serv, Boston, MA 02114 USA
关键词
Sudden cardiac death; Ventricular tachycardia and fibrillation; Genetics; Inherited arrhythmia; LONG-QT SYNDROME; POLYMORPHIC VENTRICULAR-TACHYCARDIA; ST-SEGMENT-ELEVATION; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; TERM-FOLLOW-UP; GENOTYPE-PHENOTYPE CORRELATION; GENOME-WIDE ASSOCIATION; BUNDLE-BRANCH BLOCK; BRUGADA-SYNDROME; HYPERTROPHIC CARDIOMYOPATHY;
D O I
10.1007/s11886-013-0389-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A wide range of inherited syndromes can result in ventricular arrhythmias and sudden cardiac death (SCD). The natural histories of inherited arrhythmia syndromes are highly variable and current risk stratification techniques are limited. Thus, the management of these conditions can be difficult and often involves a combination of risk assessment, lifestyle modification, cardiac interventions, counselling, and family screening. Recent advances in high throughput sequencing have enabled routine testing in patients with a high clinical index of suspicion for an inherited arrhythmia condition, and cascade screening in relatives of mutation carriers. Given the complexity in screening and data interpretation that has been introduced by recent genomic advances, individuals with inherited arrhythmia syndromes are encouraged to seek care at specialized centers with cardiovascular genetics expertise. In this review, we discuss the etiologies of SCD syndromes and discuss strategies for the evaluation of patients at risk for SCD with a focus on the role of genetic testing and family screening.
引用
收藏
页数:14
相关论文
共 50 条
  • [11] EVALUATION OF THE PATIENT WITH SUDDEN CARDIAC DEATH
    MORADY, F
    SCHEINMAN, MM
    MEDICAL CLINICS OF NORTH AMERICA, 1984, 68 (05) : 1231 - 1245
  • [12] CETUXIMAB: A POTENTIALLY UNDER RECOGNIZED ETIOLOGY OF SUDDEN CARDIAC DEATH
    Azeem, Ammaar
    Abdo, Tony
    Hussain, Syed
    CHEST, 2021, 160 (04) : 836A - 836A
  • [13] Genetic causes of sudden cardiac death in the young
    Mazzanti, Andrea
    Maragna, Riccardo
    Priori, Silvia G.
    CURRENT OPINION IN CARDIOLOGY, 2017, 32 (03) : 253 - 261
  • [14] Genetic testing to prevent sudden cardiac death
    Stallmeyer, B.
    Dittmann, S.
    Schulze-Bahr, E.
    INTERNIST, 2018, 59 (08): : 776 - 788
  • [15] Molecular genetic basis of sudden cardiac death
    Towbin, JA
    CARDIOVASCULAR PATHOLOGY, 2001, 10 (06) : 283 - 295
  • [16] Postmortem genetic testing in sudden cardiac death: To be or not to be?
    Temel, Sehime Gulsun
    Turkgenc, Burcu
    Akcay, Arzu
    Koseler, Aylin
    Yakicier, Cengiz
    JOURNAL OF BIOTECHNOLOGY, 2018, 280 : S19 - S19
  • [17] Molecular and genetic basis of sudden cardiac death
    George, Alfred L., Jr.
    JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (01): : 75 - 83
  • [18] Common genetic variants in sudden cardiac death
    George, Alfred L., Jr.
    HEART RHYTHM, 2009, 6 (11) : S3 - S9
  • [19] Molecular genetic basis of sudden cardiac death
    Towbin, JA
    PEDIATRIC CLINICS OF NORTH AMERICA, 2004, 51 (05) : 1229 - +
  • [20] Sudden cardiac death in the young: a genetic destiny?
    Thiene, Gaetano
    CLINICAL MEDICINE, 2018, 18 (02) : S17 - S23